Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01344941 · ClinicalTrials.gov registry record
Human Immune Responses Toward HIV-1 Envelope Antigens
A clinical trial, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- 8
- Enrollment target
NCT01344941: Completed study, sponsored by St. Jude Children's Research Hospital.
NCT01344941 is a clinical trial that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01344941 has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
Study Summary
The primary objectives of this study is to * Define the envelope-specific B-cell and T-cell responses in humans who have received a St. Jude HIV-1 vaccine. * Describe mechanisms of HIV-1 envelope processing and consequent B-cell and T-cell activities.
Primary Outcome
The outcome measures will be assessed in such a way that individuals will be sampled longitudinally (every 6months) until the immune response is no longer detectable by HIV ELISA or until the 5 year study period is complete, whichever comes first. A volume of 120 ml will be collected at each visit for immune response assays (both B-cell and T-cell) and 2 ml of blood will be collected for the HIV ELISA.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2010-03 |
| Est. Completion | 2015-11 |
What the finished NCT01344941 record still lists
NCT01344941 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01344941 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01344941 about?
NCT01344941 is a clinical study titled "Human Immune Responses Toward HIV-1 Envelope Antigens". The primary objectives of this study is to * Define the envelope-specific B-cell and T-cell responses in humans who have received a St. Jude HIV-1 vaccine. * Describe mechanisms of HIV-1 envelope processing and consequent B-cell and T-cell activities.
What is the current status of trial NCT01344941?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2010-03. Estimated completion is 2015-11.
Who is sponsoring clinical trial NCT01344941?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia